Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling

Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling

Bibliographic Details
Main Authors: Zhang-qi Cao, Xue-xi Wang, Li Lu, Jing-wen Xu, Xiao-bin Li, Guang-ru Zhang, Zhan-jun Ma, An-chen Shi, Yan Wang, Yu-jun Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Pharmacology
Subjects:
β-sitosterol
gemcitabine
pancreatic cancer
apoptosis
EMT
AKT
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.565535/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.565535/full

Similar Items